Leveraging AI and Cohort Data for Precision Oncology Improves Insights and Efficacy of Treatment Plans with Kathy Ford Ronin TRANSCRIPT
Download PDFSep 14, 2023
Kathy Ford is the Chief Product and Strategy Officer at Ronin, applying AI and deep data mining to determine relevant cohorts to develop better cancer treatment plans. Looking at patient-specific data, including genetics, comorbidities, and risk factors, allows medical oncologists and patients to predict results and...
Sep 14, 2023
Kathy Ford is the Chief Product and Strategy Officer at Ronin, applying AI and deep data mining to determine relevant cohorts to develop better cancer treatment plans. Looking at patient-specific data, including genetics, comorbidities, and risk factors, allows medical oncologists and patients to predict results and...
Engineered Cytokines and Attacking Solid Tumors with IL-2 Superkines with Dr. Fahar Merchant Medicenna Therapeutics TRANSCRIPT
Download PDFAug 15, 2023
Dr. Fahar Merchant, President, CEO, and Co-Founder of Medicenna Therapeutics, talks about the role cytokines play in managing the immune system, activating the system, or dampening the immune response depending on the circumstances. When the system is out of balance, pathogens and cancers can attack, or autoimmune...
Aug 15, 2023
Dr. Fahar Merchant, President, CEO, and Co-Founder of Medicenna Therapeutics, talks about the role cytokines play in managing the immune system, activating the system, or dampening the immune response depending on the circumstances. When the system is out of balance, pathogens and cancers can attack, or autoimmune...
Using Targeted Pan-RAS Inhibitors to Fight RAS-Driven Cancers with Dr. Tariq Arshad Qualigen Therapeutics TRANSCRIPT
Download PDFAug 2, 2023
Dr. Tariq Arshad is the Senior Vice President and Chief Medical Officer at Qualigen Therapeutics, addressing multiple types of RAS-driven cancers. While researchers understand RAS's role in tumorgenesis and have identified which cancers are RAS-driven, RAS has been considered an undruggable target. With a pan-RAS...